Craig-Hallum Reiterates Buy, $92 Target On Tandem Diabetes Notes 'FDA Ups The Ante With A Class I Recall Of Medtronic's 600-Series Pumps. Puts Additional Pressure On MDT, Lends Support For Tandem Going In-Network With UNH'
Benzinga_Newsdesk